Early-Life Colonization by Anelloviruses in Infants

Abstract

Anelloviruses (AVs) are found in the vast majority of the human population and are most probably part of a healthy virome. These viruses infect humans in the early stage of life, however, the characteristics of the first colonizing AVs are still unknown. We screened a collection of 107 blood samples from children between 0.4 and 64.8 months of age for the presence of three AV genera: the Alpha-, Beta- and Gammatorquevirus. The youngest child that was positive for AV was 1.2 months old, and a peak in prevalence (100% of samples positive) was reached between the twelfth and eighteenth months of life. Intriguingly, the beta- and gammatorqueviruses were detected most at the early stage of life (up to 12 months), whereas alphatorqueviruses, the most common AVs in adults, increased in prevalence in children older than 12 months. To determine whether that order of colonization may be related to oral transmission and unequal presence of AV genera in breast milk, we examined 63 breast milk samples. Thirty-two percent of the breast milk samples were positive in a qPCR detecting beta- and gammatorqueviruses, while alphatorqueviruses were detected in 10% of the samples, and this difference was significant (p = 0.00654). In conclusion, we show that beta- and gammatorqueviruses colonize humans in the first months of life and that breastfeeding could play a role in AV transmission.

1. Introduction

Anelloviruses (AVs) are small, circular single-stranded DNA viruses infecting vertebrates [1]. While found in basically all body compartments [2], AVs are considered one of the most common eukaryotic viruses in human blood [3]. AVs are widespread in the human population, however, the source and the moment of the first infection are still not clear [3,4]. Of note, higher levels of AV DNA are found in immunocompromised people, for instance, in HIV-1 positive subjects [5,6,7]. Since the HIV-1 infected individuals have significantly higher AV DNA prevalence and concentration compared to HIV-1 negative people, the transmission of AVs may be enhanced in these individuals [6].

Three AV genera are known to infect humans: Alphatorquevirus (often referred to as torque teno virus, TTV), Betatorquevirus (torque teno mini virus, TTMV), and Gammatorquevirus (torque teno midi virus, TTMDV). Alphatorquevirus is the most common in adults [8] and the most studied genus and contains 26 species, while Beta- and Gammatorquevirus contain 38 and 15 species that are officially approved as reference genomes by ICTV [9]. Even though they share similarities in genome organization, the three genera differ in genome size—3.8 to 3.9 kb for Alphatorquevirus, 3.2 kb for Gammatorquevirus, and 2.8 to 2.9 kb for Betatorquevirus [9]. Moreover, they are extremely divergent in terms of the genomic sequence [1,10].

AVs are nearly continuously shed by infants [11,12], indicating that first infections take place early in life. Umbilical cord blood is negative for alphatorquevirus DNA, thus transplacental transmission of AVs is considered unlikely [13]. Some studies have found alphatorquevirus DNA in blood as early as in the second month of life [14,15]. Of note, AVs are not only present in the blood, but also in stool samples collected in the first months of life, indicating replication in the gut at a very young age [12,16]. The peak of AV abundance in the gut was found between the sixth and twelfth months of life, after which the abundance decreases [12,16]. AVs may thus be transmitted by breastfeeding. Breast milk contains AV DNA [17,18], however, there was no association found between the breastfeeding status and AV richness in infants [19,20]. It has been shown that the human gut virome is highly dynamic in the first years of life [3,16]. We hypothesize that also the blood anellovirus virome (anellome [1]) may be unfixed in young infants. Early-life dynamics of anellome could be a part of the maturation of children’s immune systems [12,21]. To explore the hypothesis, we investigated the prevalence of three human-infecting AVs (alphatorquevirus, betatorquevirus, and gammatorquevirus) in the blood of 107 children between the age of 0.4 and 64.8 months using a set of three quantitative PCRs (qPCRs). Moreover, to investigate the significance of breastfeeding as an AV transmission route, we performed the same set of qPCRs on a collection of 64 breast milk samples. Additionally, we assessed the prevalence and viral load of AVs in 7 children’s serum and in 10 breast milk samples obtained from HIV-1 positive subjects.

2. Materials and Methods

2.1. Clinical Samples

Blood samples (serum or EDTA-plasma) were collected from 114 infants from 0.4 to 64.8 months of age (Supplementary Table S1). A total of 7 of the 114 blood samples were collected from HIV-1 infected children (CH108–CH114). Next to the blood samples, 73 breast milk samples were collected from other cohorts. Ten of these breast milk samples were collected from HIV-1-positive mothers (BM64–BM73) and 63 breast milk samples were the surplus of milk donated to the Dutch Human Milk Bank. The children and the women were not related to each other. The children’s serum samples and the HIV-1 positive breast milk samples had been anonymized. The Dutch Human Milk Bank samples were pseudo-anonymized and not traceable. Until nucleic acid isolations, the blood samples were stored at −80 °C, and the breast milk samples at −20 °C.

2.2. Nucleic Acid Isolations

One hundred µL of collected samples were lysed and the total nucleic acids were extracted using the Boom protocol [22]. This method is based on the lysing and nuclease-inactivating properties of the chaotropic agent guanidine thiocyanate (GuSCN) and the concurrent binding of all nucleic acid types by silica particles in the presence of this agent. Bound nucleic acids are subsequently washed and elution of nucleic acids is achieved by adding water (65 µL) to the silica particles. The nucleic acids were stored at −80 °C until further use.

2.3. Genus-Specific qPCRs

Three genus-specific qPCRs were performed to quantify the concentration of AV DNA in the samples. The first qPCR detects solely alphatorquevirus [23], the second detects only betatorquevirus, while the third qPCR detects both beta- and gammatorquevirus (primers are presented in Supplementary Table S2). Because of the high genetic divergence of AVs and the presence of only one sufficiently large conserved region in the genome, it was not feasible to design qPCR primers to detect solely the Gammatorquevirus genus. Dilutions of a positive control plasmid were used to construct the standard curve and calculate the sample concentrations of the viruses. The qPCR reaction mixture consisted of 2.5 µL of isolated nucleic acids, 6.25 µL of 2× Qiagen RotorGene Probe Master-mix (Qiagen, catalogue number 204574), 0.25 µL of probe, 0.5 µL of forward and 0.5 µL of reverse primer (all 10 µM) and 2.5 µL of H₂O in each sample. The reaction was performed on a Rotor-Gene machine ( Qiagen GmbH, Hilden, Germany) as follows: 95 °C for 3 min, followed by 40 cycles of 95 °C for 3 s, 60 °C for 10 s, and a final elongation step at 72 °C for 3 min. The detection limit of the AV concentration was estimated experimentally and was 1.5 × 10² copies per mL of the sample.

2.4. Statistical Analysis

All graphs and statistical analysis were performed in R version 4.1.1 equipped with the tidyverse, dplyr, and rstatix packages. The McNemar statistical test was used to compare the prevalence of the genera, the Chi-Square test to compare the AV prevalence in early and late breast milk, and the Wilcoxon sum rank test was used to compare DNA concentrations.

3. Results

3.1. Anellovirus Prevalence and DNA Concentration in Children’s Blood

Alphatorquevirus, betatorquevirus, and gammatorquevirus viral loads were quantified in 114 children’s serum (n = 112) or plasma (n = 2) samples. The children were between 0.4 to 64.8 months of age (Supplementary Table S1). Seven of the samples (CH108 to CH114) were collected from HIV-1 positive children and therefore were excluded from the overall AV prevalence analysis. Twenty-eight samples were negative in all three qPCRs. Forty-eight percent of the samples obtained from HIV-1-negative children were positive in the alphatorquevirus qPCR, 46% in the betatorquevirus qPCR, and 74% were positive in the beta + gammatorquevirus qPCR. The prevalence of Beta + Gammatorquevirus was significantly higher than that of alphatorquevirus (McNemar test, p-value = 4.89 × 10⁻⁵; Supplementary Table S3). A total of 30 out of 107 children’s blood samples (28%) were positive in all three qPCRs. All samples obtained from HIV-1 positive children (CH108 to CH114; Supplementary Table S1) were positive in all qPCRs and also showed the highest AV DNA concentrations (>10⁷ AV DNA copies per mL serum; Supplementary Figure S2).

Next, we investigated the prevalence and concentration of AVs in relation to the age of the HIV-1 negative children. The prevalence of AVs increased with age, reaching a maximum of 100% at the age between 12 and 18 months (Supplementary Figure S1A). Moreover, the concentrations of AV DNA increased with the age of children and showed the highest values after 12 months of age (Supplementary Figure S1B), however, the only significant difference was observed between the subsets from 12 to 18 months and 30 to 65 months.

We observed a significantly higher (p-value = 0.00206) prevalence of beta- and gammatorquevirus than alphatorquevirus in the children of age between 0.4 and 12 months (Figure 1A and Figure S1A, Supplementary Table S3). Between 0 and 12 months of age, less than half of the serum samples were positive for the alphatorquevirus qPCR (10 out of 50 samples, 20%). In contrast, the beta- and gammatorquevirus qPCRs were frequently positive in this age group (25 out of 50 samples, 50%). In children older than 12 months, the number of samples positive for alphatorquevirus DNA increases (41 out of 57 samples, 72%; Figure 1A,B).

Taken together, these results indicate that betatorqueviruses and/or gammatorqueviruses are the pioneer AVs infecting young children.

3.2. Prevalence of Anelloviruses in Breast Milk

Based on the hypothesis that breast milk could be the source of the first colonizing AVs in infants, we investigated a set of 73 breast milk samples. The samples were not related to the children’s samples. Ten of the breast milk samples were collected from HIV-1-positive women and thus were not included in the analysis of the overall prevalence of AVs in breast milk. A total of 24 out of 63 HIV-1 negative breast milk samples were positive for AV DNA (38% positive; Supplementary Table S1), with a substantial part of the samples qPCR positive in the Beta + Gammatorquevirus qPCR (32% positive samples), followed by Betatorquevirus qPCR (16% positive) and Alphatorquevirus qPCR (10% positive). The difference in the prevalence of Alphatorquevirus versus Beta + Gammatorquevirus was statistically significant (p-value = 0.00654; Supplementary Table S3). Six out of ten breast milk samples obtained from HIV-1 positive mothers were positive for AV DNA, five of the samples were positive in Alphatorquevirus, two in Betatorquevirus and six in Beta- and Gammatorquevirus qPCR (samples BM64–BM73; Supplementary Table S1).

We observed a similar AV DNA prevalence in early breast milk (collected between 0 and 2 months after an infant’s birth; 34% of the samples were positive for AV DNA) and late breast milk (after 2 months; 40% of samples were positive for AV DNA). Thus, the overall prevalence of AV in breast milk did not significantly change over time (Chi-square test, p-value = 0.8563; Figure 2, Supplementary Table S3).

In the breast milk samples, the mean DNA concentration measured in the Alphatorquevirus qPCR showed higher values than the other qPCRs, but this difference was not statistically significant (Wilcoxon test, p > 0.05). Of note are the high AV DNA concentrations measured in the breast milk samples obtained from three HIV-1 positive women: samples BM66, BM70, and BM71 contained >10⁶ AV DNA copies per mL of milk (Supplementary Table S1, Supplementary Figure S2).

4. Discussion

In this study, we assessed the prevalence of AV in the blood of children of various ages and in breast milk. Most importantly, there was a higher prevalence of beta- and possibly also gammatorquevirus in the children between 0.4 and 12 months of age, compared to alphatorquevirus prevalence. We, therefore, propose that the alphatorquevirus is less likely to belong to the pioneer population of the children’s blood, but the Beta- and Gammatorquevirus do act more often as the first colonizers.

From 4 to 6 months after birth, most infants start with the initiation of solid food, next to breast milk (or formula). In this period, also the largest changes in bacteriome [24] and virome [16] are observed, which is connected with the cessation of the supply of breast milk-derived antibodies. In our dataset, the prevalence of alphatorquevirus indeed increased together with the age of children, and this genus was similarly common in children older than 12 months compared to the other two AV genera. Alphatorquevirus is the most common AV genus in adult blood [8,25]. We speculate that the blood anellome [1] may reach a compositional equilibrium around the age of 12 months.

There are a few hypothetical transmission routes of AVs: oral, airway, sexual transmission, or blood–blood contact [1,26]. Since the first infections happen early in life, it is most likely that the mother is the source of the pioneer viruses that populate the child. We detected AV DNA in nearly 40% of the tested breast milk samples. Thus, breastfeeding may play an important role in the transmission of AV from mother-to-child, which is in line with the findings reported by Ohto and colleagues [27]. More recent studies however showed that AVs are not particularly abundant in breast milk [17], and we also do not find high concentrations in the breast milk of healthy mothers; still, a low concentration may be enough to cause the colonization of AV in infants. In our dataset, the beta- and/or gammatorquevirus were the most prevalent in children’s blood samples. We observed the same unequal presence in breast milk, since 32% of breast milk samples were positive for beta- and/or gammatorquevirus, and this prevalence was significantly higher than the one of alphatorquevirus (10%). However, it is important to mention that the breastfeeding status of the tested children was unknown. Therefore, we propose that transmission via breast milk might be an important but not sole source of pioneer AVs in children; however, more research is needed to further support this claim.

It is of note, however, that we observed higher AV DNA concentrations in the blood of HIV-1-infected children and the breast milk of HIV-1-positive women compared to samples derived from HIV-1 negative subjects. It has been reported that individuals infected by HIV-1 tend to have higher levels of AV [5,7] and that there is a positive correlation between the levels of immunosuppression and AV abundance [28]. The HIV-1 positive children from our dataset were not breastfed, but still contained high levels of AVs in their blood already at 2 months of age. Due to the lack of breastfeeding, the AV transmission in these children must have happened via a different route. A metagenomic study involving serum, stool, nasopharyngeal swabs, and breast milk samples from mothers together with an analysis of longitudinally collected serum samples of their infants may not only provide information on AV infection compartmentalization but also reveal the routes that transmit AVs.

Author Contributions

Conceptualization, J.K., A.C. and L.v.d.H.; supervision, L.v.d.H.; methodology, J.K., A.C. and M.D.; resources, M.B., J.B.v.G. and B.J.v.K.; investigation, J.K., A.C., A.L.T., M.F.J. and M.D.; visualization, A.C. and J.K.; writing—original draft preparation, J.K.; writing—review and editing, L.v.d.H., A.C., A.L.T., M.F.J., M.D., M.B., J.B.v.G. and B.J.v.K.; funding acquisition, L.v.d.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a grant from the European Union’s Horizon 2020 research and innovation program, under the Marie Skłodowska-Curie Actions grant agreement No. 721367 (HONOURs) and Amsterdam UMC funding connected to HONOURs.

Institutional Review Board Statement

The children’s blood samples were obtained from the clinic of the Amsterdam University Medical Center (location AMC) of the University of Amsterdam, the Netherlands. The legal guardians of each child approved the use of the blood samples for scientific purposes. The surplus of milk donated to the Dutch Human Milk Bank was used in the experiments. Each individual donor approved the use of their surplus milk for scientific purposes by means of a written declaration. The process was approved by the Institutional Review Board of VUmc, Amsterdam, the Netherlands (approval code: NL37296.029.11, approval date: 4 January 2012). The samples from HIV-1 positive subjects were obtained from The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service Amsterdam, the Amsterdam UMC of the University of Amsterdam, Medical Center Jan van Goyen and the HIV Focus Center of the DC-Clinics, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment. The Amsterdam Cohort Studies on HIV infection and AIDS were approved by the Medical Ethics Committee of the Amsterdam University Medical Center of the University of Amsterdam, the Netherlands (MEC 07/182).

Informed Consent Statement

Informed consent was obtained from all subjects or legal guardians of the subjects.

Data Availability Statement

All generated data (qPCR results) are included in the article and in the supplement. The R code that was used to generate figures and perform the statistical analysis is available at a GitHub repository under the following link: https://github.com/joannakaczorowska/firstcolonizer (accessed on 20 April 2022).

Conflicts of Interest

The authors declare no conflict of interest.

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Figure 1. Anellovirus concentration in the children’s blood over months. (A) Anellovirus concentration in the first 12 months of life and (B) anellovirus concentration in children aged 12 months until 65 months. All samples are arranged in the order of children’s age and the age of 6 months is depicted with a vertical line. The samples under the horizontal line were either negative for the viruses, or samples contained concentrations below the cutoff. Filled black dots represent alphatorquevirus white dots betatorqueviruses, and gray dots gamma- or betatorqueviruses.

Figure 2. Anellovirus concentration in breast milk. All samples are arranged in the order of children’s age at the moment of the breast milk collection. The samples under the horizontal line were either negative for the viruses, or samples contained concentrations below the cutoff. Filled black dots represent alphatorqueviruses, white dots betatorqueviruses, and gray dots gamma- or betatorqueviruses.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/v14050865/s1, Figure S1: Anellovirus prevalence and concentration at different children ages; Figure S2: Comparison of AV DNA concentration in samples from HIV-1 positive subjects with HIV-1 negative subjects; Table S1: List of the clinical samples used in the study. The presence of the three genera was evaluated using a genus-specific qPCR; Table S2: The list of primers used in this study; Table S3: The results of statistical analysis comparing the prevalence of AV genera in children and in breastmilk.

References

1. Kaczorowska, J.; van der Hoek, L. Human anelloviruses: Diverse, omnipresent and commensal members of the virome. FEMS Microbiol. Rev.; 2020; 44, pp. 305-313. [DOI: https://dx.doi.org/10.1093/femsre/fuaa007] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32188999]

2. Kumata, R.; Ito, J.; Takahashi, K.; Suzuki, T.; Sato, K. A tissue level atlas of the healthy human virome. BMC Biol.; 2020; 18, 55. [DOI: https://dx.doi.org/10.1186/s12915-020-00785-5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32493363]

3. Liang, G.; Bushman, F.D. The human virome: Assembly, composition and host interactions. Nat. Rev. Microbiol.; 2021; 19, pp. 514-527. [DOI: https://dx.doi.org/10.1038/s41579-021-00536-5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33785903]

4. Virgin, H.W.; Wherry, E.J.; Ahmed, R. Redefining Chronic Viral Infection. Cell; 2009; 138, pp. 30-50. [DOI: https://dx.doi.org/10.1016/j.cell.2009.06.036]

5. Thom, K.; Petrik, J. Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in tissues of HIV infected individuals. J. Med. Virol.; 2007; 79, pp. 1-7. [DOI: https://dx.doi.org/10.1002/jmv.20756]

6. Nasser, T.F.; de Oliveira, K.B.; Reiche, E.M.V.; Amarante, M.K.; Fungaro, M.H.P.; Watanabe, M.A.E. Detection of TT virus in HIV-1 exposed but uninfected individuals and in HIV-1 infected patients and its influence on CD4+ lymphocytes and viral load. Microb. Pathog.; 2009; 47, pp. 33-37. [DOI: https://dx.doi.org/10.1016/j.micpath.2009.04.010]

7. Liu, K.; Li, Y.; Xu, R.; Zhang, Y.; Zheng, C.; Wan, Z.; Li, H.; Yang, Z.; Jin, X.; Hao, P. et al. HIV-1 Infection Alters the Viral Composition of Plasma in Men Who Have Sex with Men. mSphere; 2021; 6, e00081-21. [DOI: https://dx.doi.org/10.1128/mSphere.00081-21]

8. Cebriá-Mendoza, M.; Arbona, C.; Larrea, L.; Díaz, W.; Arnau, V.; Peña, C.; Bou, J.V.; Sanjuán, R.; Cuevas, J.M. Deep viral blood metagenomics reveals extensive anellovirus diversity in healthy humans. Sci. Rep.; 2021; 11, 6921. [DOI: https://dx.doi.org/10.1038/s41598-021-86427-4]

9. Varsani, A.; Opriessnig, T.; Celer, V.; Maggi, F.; Okamoto, H.; Blomström, A.-L.; Cadar, D.; Harrach, B.; Biagini, P.; Kraberger, S. Taxonomic update for mammalian anelloviruses (family Anelloviridae). Arch. Virol.; 2021; 166, pp. 2943-2953. [DOI: https://dx.doi.org/10.1007/s00705-021-05192-x]

10. Arze, C.A.; Springer, S.; Dudas, G.; Patel, S.; Bhattacharyya, A.; Swaminathan, H.; Brugnara, C.; Delagrave, S.; Ong, T.; Kahvejian, A. et al. Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome. Cell Host Microbe; 2021; 29, pp. 1305-1315.e6. [DOI: https://dx.doi.org/10.1016/j.chom.2021.07.001]

11. Kapusinszky, B.; Minor, P.; Delwart, E. Nearly Constant Shedding of Diverse Enteric Viruses by Two Healthy Infants. J. Clin. Microbiol.; 2012; 50, pp. 3427-3434. [DOI: https://dx.doi.org/10.1128/JCM.01589-12] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22875894]

12. Lim, E.; Zhou, Y.; Zhao, G.; Bauer, I.K.; Droit, L.; Ndao, I.M.; Warner, B.B.; Tarr, P.I.; Wang, D.; Holtz, L.R. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat. Med.; 2015; 21, pp. 1228-1234. [DOI: https://dx.doi.org/10.1038/nm.3950]

13. Tyschik, E.A.; Shcherbakova, S.M.; Ibragimov, R.R.; Rebrikov, D.V. Transplacental transmission of torque teno virus. Virol. J.; 2017; 14, 92. [DOI: https://dx.doi.org/10.1186/s12985-017-0762-0] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28482844]

14. Komatsu, H.; Inui, A.; Sogo, T.; Kuroda, K.; Tanaka, T.; Fujisawa, T. TTV infection in children born to mothers infected with TTV but not with HBV, HCV, or HIV. J. Med. Virol.; 2004; 74, pp. 499-506. [DOI: https://dx.doi.org/10.1002/jmv.20204] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15368510]

15. Tyschik, E.A.; Rasskazova, A.S.; Degtyareva, A.; Rebrikov, D.V.; Sukhikh, G.T. Torque teno virus dynamics during the first year of life. Virol. J.; 2018; 15, 96. [DOI: https://dx.doi.org/10.1186/s12985-018-1007-6]

16. Taboada, B.; Morán, P.; Serrano-Vázquez, A.; Iša, P.; Rojas-Velázquez, L.; Pérez-Juárez, H.; López, S.; Torres, J.; Ximenez, C.; Arias, C.F. The gut virome of healthy children during the first year of life is diverse and dynamic. PLoS ONE; 2021; 16, e0240958. [DOI: https://dx.doi.org/10.1371/journal.pone.0240958]

17. Maqsood, R.; Reus, J.B.; Wu, L.I.; Holland, L.A.; Nduati, R.; Mbori-Ngacha, D.; Maleche-Obimbo, E.; Begnel, E.R.; Gantt, S.; Ojee, E. et al. Breast Milk Virome and Bacterial Microbiome Resilience in Kenyan Women Living with HIV. mSystems; 2021; 6, e01079-20. [DOI: https://dx.doi.org/10.1128/mSystems.01079-20]

18. Schröter, M.; Polywka, S.; Zöllner, B.; Schäfer, P.; Laufs, R.; Feucht, H.-H. Detection of TT Virus DNA and GB Virus Type C/Hepatitis G Virus RNA in Serum and Breast Milk: Determination of Mother-to-Child Transmission. J. Clin. Microbiol.; 2000; 38, pp. 745-747. [DOI: https://dx.doi.org/10.1128/JCM.38.2.745-747.2000]

19. McCann, A.; Ryan, F.; Stockdale, S.; Dalmasso, M.; Blake, T.; Ryan, C.A.; Stanton, C.; Mills, S.; Ross, R.; Hill, C. Viromes of one year old infants reveal the impact of birth mode on microbiome diversity. PeerJ; 2018; 6, e4694. [DOI: https://dx.doi.org/10.7717/peerj.4694]

20. Beller, L.; Deboutte, W.; Vieira-Silva, S.; Falony, G.; Tito, R.Y.; Rymenans, L.; Yinda, C.K.; Vanmechelen, B.; Van Espen, L.; Jansen, D. et al. The virota and its transkingdom interactions in the healthy infant gut. Proc. Natl. Acad. Sci. USA; 2022; 119, 119. [DOI: https://dx.doi.org/10.1073/pnas.2114619119]

21. Canuti, M.; Buka, S.; Farsani, S.M.J.; Munnink, B.B.O.; Jebbink, M.F.; van Beveren, N.J.; de Haan, L.; Goldstein, J.; Seidman, L.J.; Tsuang, M.T. et al. Reduced maternal levels of common viruses during pregnancy predict offspring psychosis: Potential role of enhanced maternal immune activity?. Schizophr. Res.; 2015; 166, pp. 248-254. [DOI: https://dx.doi.org/10.1016/j.schres.2015.04.037] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26004694]

22. Boom, R.; Sol, C.J.; Salimans, M.M.; Jansen, C.L.; Dillen, P.M.W.-V.; van der Noordaa, J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol.; 1990; 28, pp. 495-503. [DOI: https://dx.doi.org/10.1128/jcm.28.3.495-503.1990] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1691208]

23. Vasilyev, E.V.; Trofimov, D.Y.; Tonevitsky, A.G.; Ilinsky, V.V.; O Korostin, D.; Rebrikov, D.V. Torque Teno Virus (TTV) distribution in healthy Russian population. Virol. J.; 2009; 6, 134. [DOI: https://dx.doi.org/10.1186/1743-422X-6-134] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19735552]

24. Hornef, M.W.; Torow, N. ‘Layered immunity’ and the ‘neonatal window of opportunity’—Timed succession of non-redundant phases to establish mucosal host–microbial homeostasis after birth. Immunology; 2019; 159, pp. 15-25. [DOI: https://dx.doi.org/10.1111/imm.13149]

25. Spandole-Dinu, S.; Cimponeriu, D.G.; Crăciun, A.-M.; Radu, I.; Nica, S.; Toma, M.; Alexiu, O.A.; Iorga, C.S.; Berca, L.-M.; Nica, R. Prevalence of human anelloviruses in Romanian healthy subjects and patients with common pathologies. BMC Infect. Dis.; 2018; 18, 334. [DOI: https://dx.doi.org/10.1186/s12879-018-3248-9]

26. Spandole, S.; Cimponeriu, D.; Berca, L.M.; Mihăescu, G. Human anelloviruses: An update of molecular, epidemiological and clinical aspects. Arch. Virol.; 2015; 160, pp. 893-908. [DOI: https://dx.doi.org/10.1007/s00705-015-2363-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25680568]

27. Ohto, H.; Ujiie, N.; Takeuchi, C.; Sato, A.; Hayashi, A.; Ishiko, H.; Nishizawa, T. TT Virus Infection during Childhood. Transfusion; 2002; 42, pp. 892-898. [DOI: https://dx.doi.org/10.1046/j.1537-2995.2002.00150.x]

28. Focosi, D.; Antonelli, G.; Pistello, M.; Maggi, F. Torquetenovirus: The human virome from bench to bedside. Clin. Microbiol. Infect.; 2016; 22, pp. 589-593. [DOI: https://dx.doi.org/10.1016/j.cmi.2016.04.007]